Apr 25, 2024 8:00am EDT FibroBiologics Plans to Collaborate with Charles River to Manufacture Fibroblast-based Spheroids
Apr 11, 2024 9:31am EDT FibroBiologics Granted Patent for Regeneration of Cartilage-Type Cells by the Australian Patent Office
Apr 04, 2024 9:31am EDT FibroBiologics Presents Data from Dermal Fibroblast Spheroid-based Treatment of Chronic Wounds in a Diabetes Mouse Model at Advanced Wound Care Summit USA
Mar 28, 2024 9:31am EDT FibroBiologics Files Patent Application Covering Fibroblast-based Technology for the Potential Treatment of Lupus
Mar 19, 2024 9:31am EDT FibroBiologics Announces Preliminary Proof of Concept for Fibroblast-based Diabetes Treatment